Safety, tolerability and pharmacodynamics of a novel immunomodulator, MIS416, in patients with chronic progressive multiple sclerosis

Overview of attention for article published in Multiple Sclerosis Journal – Experimental, Translational and Clinical, May 2015

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (65th percentile)
Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

twitter: 1 X user
facebook: 1 Facebook page

wikipedia: 1 Wikipedia page

Readers on

mendeley: 20 Mendeley

So far, Altmetric has seen 1 public wall post.

SAGE Neurology, 31 May 2015

Safety, tolerability

This page shows the most recent Facebook posts that mention this research output. Click here to find out how to access more activity.